The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of diagnostic and end-of-induction Curie scores in tandem autologous hematopoietic cell transplant for patients with high-risk neuroblastoma: A report from the Children’s Oncology Group.
 
Keri A. Streby
Consulting or Advisory Role - Amgen; Innervate RAdiopharmaceuticals; Ymabs Therapeutics Inc
Research Funding - United Therapeutics (Inst)
 
Marguerite T. Parisi
No Relationships to Disclose
 
Barry L. Shulkin
Consulting or Advisory Role - Navidea
 
Brian LaBarre
No Relationships to Disclose
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Lisa Diller
Stock and Other Ownership Interests - Amgen (I); Apellis Pharmaceuticals (I); AstraZeneca (I); Baxter (I); crispr therapeutics (I); Intellia Therapeutics (I); LabCorp (I); Novartis (I); Novo Nordisk (I); Roche (I)
Patents, Royalties, Other Intellectual Property - My husband holds a patent with Massachusetts General Hospital for a drug currently in clinical trials. The drug is an inhibitor of BMP-1 (Alk2) receptor and is being studied in anemia of myelodysplastic syndrome and high-hepcidin level-associated anemias. (I)
 
Stephan A. Grupp
Consulting or Advisory Role - Adaptimmune; Alimera Sciences; Cabaletta Bio; Cellular Biomedicine Group; crispr therapeutics/Vertex; Humanigen; Janssen; Jazz Pharmaceuticals; Novartis; Roche; TCR2 Therapeutics
Research Funding - Jazz Pharmaceuticals (Inst); Kite/Gilead (Inst); Novartis (Inst); SERVIER (Inst); Vertex (Inst)
Patents, Royalties, Other Intellectual Property - UPenn Toxicity management patent (Inst)
Expert Testimony - Juno Therapeutics
 
Katherine K. Matthay
Consulting or Advisory Role - Innervate RAdiopharmaceuticals; Resonance
 
Stephan D. Voss
No Relationships to Disclose
 
Alice L. Yu
Leadership - OPKO Health
Stock and Other Ownership Interests - OPKO Health/GeneDx
Honoraria - EUSA Pharma
Consulting or Advisory Role - OBI Pharma
Speakers' Bureau - EUSA Pharma
Research Funding - United Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - cancer targeting peptides; Globo H-Diphtheria toxoid vaccine for cancer therapy; Methods for suppressing cancer by inhibition of TMCC3; NKT stimulatory phenyl-glycolipids for cancer therapy and vaccine adjuvant
Travel, Accommodations, Expenses - EUSA Pharma
 
Wendy B. London
Consulting or Advisory Role - Jubilant Radiopharma; Merck
Research Funding - Agios; Aileron Therapeutics; Bluebird Bio; Bristol-Myers Squibb; Novartis
 
Julie R. Park
No Relationships to Disclose
 
Gregory A. Yanik
No Relationships to Disclose
 
Arlene Naranjo
Consulting or Advisory Role - Novartis